Literature DB >> 12920258

Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance.

T Gerriets1, E Stolz, M Walberer, M Kaps, G Bachmann, M Fisher.   

Abstract

BACKGROUND AND
PURPOSE: Permanent middle cerebral artery occlusion (MCAO) with the use of the suture technique causes hypothalamic damage with subsequent hyperthermia, which can confound neuroprotective drug studies. In the present study the neuroprotective effects of dizocilpine (MK-801) were compared in different permanent MCAO models with and without hypothalamic damage and hyperthermia.
METHODS: Sixty Sprague-Dawley rats were treated with MK-801 or placebo, beginning 15 minutes before MCAO, and assigned to the following groups: suture MCAO (group I), macrosphere MCAO without hypothalamic damage (group II), or macrosphere MCAO with intentionally induced hypothalamic infarction (group III). Body temperature was measured at 3, 6, and 24 hours. Lesion size was determined after 24 hours (2,3,5-triphenyltetrazolium chloride staining).
RESULTS: Hypothalamic damage was present in animals in group I and was intentionally induced in group III with the use of a modified macrosphere MCAO technique. Body temperature was significantly increased 3, 6, and 24 hours after MCAO in these 2 groups of animals. Hypothalamic damage and subsequent hyperthermia could be avoided effectively by limiting the number of macrospheres (group II). MK-801 provided a highly significant neuroprotective effect in group II but not in groups I and III.
CONCLUSIONS: Hypothalamic damage with subsequent hyperthermia masked the neuroprotective effect of MK-801. This side effect can be avoided by using the macrosphere MCAO technique with a limited number of spheres. This model therefore may be more appropriate to study the effects of neuroprotective drugs in permanent focal cerebral ischemia than the suture method.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920258     DOI: 10.1161/01.STR.0000087171.34637.A9

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils.

Authors:  Vesna Selakovic; Branka Janac; Lidija Radenovic
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

2.  Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury.

Authors:  Dorothy P Schafer; Smita Jha; Fudong Liu; Trupti Akella; Louise D McCullough; Matthew N Rasband
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

3.  Non-invasive treatment with near-infrared light: A novel mechanisms-based strategy that evokes sustained reduction in brain injury after stroke.

Authors:  Christos D Strubakos; Michelle Malik; Joseph M Wider; Icksoo Lee; Christian A Reynolds; Panayiotis Mitsias; Karin Przyklenk; Maik Hüttemann; Thomas H Sanderson
Journal:  J Cereb Blood Flow Metab       Date:  2019-05-21       Impact factor: 6.200

Review 4.  Rodent models of focal stroke: size, mechanism, and purpose.

Authors:  S Thomas Carmichael
Journal:  NeuroRx       Date:  2005-07

Review 5.  The macrosphere model-an embolic stroke model for studying the pathophysiology of focal cerebral ischemia in a translational approach.

Authors:  Maureen Walberer; Maria Adele Rueger
Journal:  Ann Transl Med       Date:  2015-06

6.  Evaluation of the middle cerebral artery occlusion techniques in the rat by in-vitro 3-dimensional micro- and nano computed tomography.

Authors:  Alexander C Langheinrich; Mesut Yeniguen; Anne Ostendorf; Simone Marhoffer; Marian Kampschulte; Georg Bachmann; Erwin Stolz; Tibo Gerriets
Journal:  BMC Neurol       Date:  2010-05-28       Impact factor: 2.474

Review 7.  Small molecule inhibitors in the treatment of cerebral ischemia.

Authors:  Jerry J Flores; Yang Zhang; Damon W Klebe; Tim Lekic; Weiling Fu; John H Zhang
Journal:  Expert Opin Pharmacother       Date:  2014-02-04       Impact factor: 3.889

8.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

9.  Ischemic stroke and neuroprotection.

Authors:  Io Onwuekwe; B Ezeala-Adikaibe
Journal:  Ann Med Health Sci Res       Date:  2012-07

10.  Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT(1A) agonist in rat models of ischaemic stroke.

Authors:  Maria Ashioti; John S Beech; Andrew S Lowe; Michel Bernanos; Andrew McCreary; Michel M Modo; Steve C R Williams
Journal:  BMC Neurosci       Date:  2009-07-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.